Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Repair | 27 | 2024 | 2046 | 3.480 |
Why?
|
DNA Breaks, Double-Stranded | 19 | 2024 | 613 | 3.380 |
Why?
|
Phosphoprotein Phosphatases | 12 | 2019 | 329 | 2.860 |
Why?
|
MicroRNAs | 27 | 2024 | 3816 | 2.600 |
Why?
|
BRCA1 Protein | 11 | 2024 | 1158 | 2.150 |
Why?
|
Genomic Instability | 8 | 2024 | 709 | 1.990 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2024 | 112 | 1.540 |
Why?
|
DNA Damage | 22 | 2023 | 2449 | 1.370 |
Why?
|
RNA-Binding Proteins | 7 | 2024 | 1898 | 1.260 |
Why?
|
G1 Phase | 5 | 2019 | 403 | 1.260 |
Why?
|
Ovarian Neoplasms | 15 | 2024 | 4878 | 1.250 |
Why?
|
DNA | 15 | 2024 | 7213 | 1.200 |
Why?
|
DNA Replication | 8 | 2024 | 1418 | 1.050 |
Why?
|
Radiation Tolerance | 5 | 2018 | 478 | 0.990 |
Why?
|
Histones | 10 | 2023 | 2580 | 0.990 |
Why?
|
Cyclin B1 | 2 | 2024 | 58 | 0.970 |
Why?
|
Mitosis | 4 | 2024 | 1188 | 0.910 |
Why?
|
Multiprotein Complexes | 4 | 2024 | 1120 | 0.820 |
Why?
|
Nucleotidyltransferases | 1 | 2024 | 244 | 0.800 |
Why?
|
Granzymes | 6 | 2009 | 277 | 0.740 |
Why?
|
Cell Line, Tumor | 24 | 2024 | 16990 | 0.650 |
Why?
|
Cytoplasmic Dyneins | 1 | 2018 | 24 | 0.630 |
Why?
|
HeLa Cells | 10 | 2024 | 3094 | 0.580 |
Why?
|
Down-Regulation | 6 | 2016 | 2919 | 0.570 |
Why?
|
Protein Processing, Post-Translational | 4 | 2020 | 1974 | 0.530 |
Why?
|
Serum | 1 | 2017 | 209 | 0.530 |
Why?
|
Phosphorylation | 15 | 2020 | 8321 | 0.530 |
Why?
|
Protein Binding | 10 | 2024 | 9353 | 0.520 |
Why?
|
Whole-Body Irradiation | 2 | 2023 | 433 | 0.510 |
Why?
|
Phosphoproteins | 6 | 2024 | 2448 | 0.500 |
Why?
|
Genes, BRCA1 | 1 | 2018 | 764 | 0.480 |
Why?
|
Cisplatin | 2 | 2018 | 1652 | 0.460 |
Why?
|
Replication Protein A | 2 | 2014 | 53 | 0.460 |
Why?
|
Organoplatinum Compounds | 1 | 2016 | 407 | 0.460 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2024 | 2917 | 0.450 |
Why?
|
Conserved Sequence | 1 | 2017 | 1163 | 0.440 |
Why?
|
Cell Lineage | 2 | 2021 | 2557 | 0.440 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2020 | 2872 | 0.430 |
Why?
|
DNA-Binding Proteins | 7 | 2024 | 9610 | 0.430 |
Why?
|
DNA Breaks | 1 | 2013 | 47 | 0.430 |
Why?
|
RNA Interference | 9 | 2019 | 2832 | 0.430 |
Why?
|
Radiation Injuries | 2 | 2018 | 1189 | 0.420 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 5305 | 0.400 |
Why?
|
Lysine | 1 | 2017 | 993 | 0.400 |
Why?
|
Glioblastoma | 3 | 2016 | 3483 | 0.390 |
Why?
|
BRCA2 Protein | 5 | 2023 | 805 | 0.390 |
Why?
|
Transforming Growth Factor beta | 2 | 2016 | 1964 | 0.380 |
Why?
|
Exodeoxyribonucleases | 3 | 2007 | 192 | 0.370 |
Why?
|
Phthalazines | 3 | 2021 | 383 | 0.370 |
Why?
|
Cystadenocarcinoma, Serous | 3 | 2021 | 478 | 0.360 |
Why?
|
Carrier Proteins | 3 | 2021 | 4937 | 0.360 |
Why?
|
Lymphocytes | 3 | 2014 | 2612 | 0.350 |
Why?
|
Signal Transduction | 11 | 2024 | 23447 | 0.330 |
Why?
|
Pyrazines | 4 | 2024 | 1202 | 0.330 |
Why?
|
RNA, Untranslated | 1 | 2013 | 459 | 0.330 |
Why?
|
Cell Cycle Proteins | 7 | 2022 | 3449 | 0.320 |
Why?
|
Antineoplastic Agents | 6 | 2023 | 13642 | 0.310 |
Why?
|
RNA, Small Interfering | 9 | 2019 | 3430 | 0.310 |
Why?
|
Apoptosis | 8 | 2023 | 9490 | 0.310 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1886 | 0.310 |
Why?
|
Pancreatic Neoplasms | 2 | 2024 | 5368 | 0.300 |
Why?
|
Cell Death | 3 | 2009 | 1679 | 0.290 |
Why?
|
Membrane Proteins | 1 | 2024 | 7859 | 0.290 |
Why?
|
Isoxazoles | 3 | 2024 | 232 | 0.280 |
Why?
|
DNA Topoisomerases, Type II | 2 | 2022 | 122 | 0.280 |
Why?
|
Blood Cells | 1 | 2009 | 305 | 0.280 |
Why?
|
Nucleoside-Diphosphate Kinase | 1 | 2006 | 17 | 0.270 |
Why?
|
Cell Cycle | 6 | 2019 | 2932 | 0.270 |
Why?
|
Carcinoma | 1 | 2018 | 2330 | 0.270 |
Why?
|
Mutation | 14 | 2024 | 30053 | 0.260 |
Why?
|
Animals | 34 | 2024 | 168475 | 0.260 |
Why?
|
Humans | 80 | 2024 | 761596 | 0.250 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2019 | 655 | 0.250 |
Why?
|
HEK293 Cells | 4 | 2024 | 4281 | 0.250 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2018 | 360 | 0.240 |
Why?
|
Coenzymes | 1 | 2024 | 102 | 0.230 |
Why?
|
Serine Endopeptidases | 2 | 2006 | 1023 | 0.230 |
Why?
|
Mice | 22 | 2024 | 81539 | 0.230 |
Why?
|
Chromatin | 6 | 2023 | 2961 | 0.230 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2008 | 1351 | 0.230 |
Why?
|
S Phase | 2 | 2022 | 421 | 0.220 |
Why?
|
Repressor Proteins | 2 | 2012 | 2986 | 0.220 |
Why?
|
Poly(ADP-ribose) Polymerases | 4 | 2014 | 426 | 0.220 |
Why?
|
Genes, Immunoglobulin | 1 | 2004 | 285 | 0.210 |
Why?
|
Telomere-Binding Proteins | 3 | 2020 | 119 | 0.210 |
Why?
|
Deoxycytidine | 3 | 2024 | 877 | 0.210 |
Why?
|
Binding Sites | 4 | 2021 | 6056 | 0.210 |
Why?
|
Platinum | 3 | 2020 | 220 | 0.210 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3397 | 0.210 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2007 | 647 | 0.200 |
Why?
|
Immunity, Innate | 2 | 2024 | 3066 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2020 | 8554 | 0.200 |
Why?
|
Cell Line | 10 | 2020 | 15601 | 0.200 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2018 | 487 | 0.190 |
Why?
|
Feedback, Physiological | 1 | 2004 | 476 | 0.190 |
Why?
|
Piperazines | 2 | 2014 | 2523 | 0.190 |
Why?
|
Antigens, Nuclear | 2 | 2016 | 184 | 0.190 |
Why?
|
Neoplasms, Bone Tissue | 1 | 2020 | 7 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11742 | 0.180 |
Why?
|
K562 Cells | 4 | 2010 | 642 | 0.180 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2020 | 72 | 0.170 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2019 | 20 | 0.170 |
Why?
|
Pyrimidines | 3 | 2022 | 3028 | 0.170 |
Why?
|
Phosphoserine | 1 | 2019 | 203 | 0.170 |
Why?
|
Lim Kinases | 1 | 2019 | 8 | 0.160 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22174 | 0.160 |
Why?
|
Spodoptera | 2 | 2010 | 141 | 0.160 |
Why?
|
Tumor Suppressor Proteins | 4 | 2014 | 2805 | 0.160 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 9420 | 0.160 |
Why?
|
Brain Neoplasms | 3 | 2018 | 9032 | 0.160 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2024 | 1728 | 0.150 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2018 | 27 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2024 | 4580 | 0.150 |
Why?
|
G-Quadruplexes | 1 | 2020 | 143 | 0.150 |
Why?
|
Phenylenediamines | 1 | 2018 | 88 | 0.140 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2018 | 104 | 0.140 |
Why?
|
Triage | 1 | 2024 | 986 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1406 | 0.140 |
Why?
|
Cell Division | 3 | 2012 | 4465 | 0.140 |
Why?
|
Benzoquinones | 2 | 2014 | 198 | 0.140 |
Why?
|
Cell Differentiation | 4 | 2010 | 11530 | 0.130 |
Why?
|
Models, Molecular | 2 | 2024 | 5439 | 0.130 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17635 | 0.130 |
Why?
|
RNA-Binding Protein EWS | 1 | 2018 | 210 | 0.130 |
Why?
|
Lupus Erythematosus, Cutaneous | 2 | 2007 | 73 | 0.130 |
Why?
|
Female | 23 | 2024 | 392705 | 0.130 |
Why?
|
Oncogenes | 2 | 2021 | 1222 | 0.130 |
Why?
|
Oligonucleotides, Antisense | 2 | 2016 | 461 | 0.130 |
Why?
|
Protein Transport | 2 | 2014 | 1967 | 0.130 |
Why?
|
Protein Subunits | 2 | 2010 | 943 | 0.130 |
Why?
|
G2 Phase | 2 | 2014 | 136 | 0.130 |
Why?
|
Cell Nucleus | 2 | 2023 | 2910 | 0.130 |
Why?
|
Lactams, Macrocyclic | 2 | 2014 | 318 | 0.130 |
Why?
|
RNA, Messenger | 7 | 2014 | 12794 | 0.130 |
Why?
|
Glioma | 2 | 2022 | 3455 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2012 | 988 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2201 | 0.120 |
Why?
|
Protein Phosphatase 2 | 2 | 2008 | 231 | 0.120 |
Why?
|
Receptors, Antigen | 2 | 2005 | 51 | 0.120 |
Why?
|
Base Sequence | 3 | 2016 | 12441 | 0.120 |
Why?
|
Gene Expression Regulation | 6 | 2017 | 11904 | 0.120 |
Why?
|
Proteome | 1 | 2024 | 1862 | 0.120 |
Why?
|
Methylation | 1 | 2017 | 1084 | 0.110 |
Why?
|
Comet Assay | 2 | 2012 | 75 | 0.110 |
Why?
|
Nuclear Proteins | 5 | 2020 | 5799 | 0.110 |
Why?
|
Salvage Therapy | 1 | 2020 | 1263 | 0.110 |
Why?
|
Histone Deacetylases | 1 | 2018 | 720 | 0.110 |
Why?
|
DNA Modification Methylases | 1 | 2014 | 210 | 0.110 |
Why?
|
Rad51 Recombinase | 2 | 2013 | 189 | 0.110 |
Why?
|
Telomere | 1 | 2019 | 943 | 0.110 |
Why?
|
3' Untranslated Regions | 3 | 2011 | 519 | 0.110 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 774 | 0.110 |
Why?
|
Perforin | 3 | 2008 | 167 | 0.110 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20100 | 0.110 |
Why?
|
Substrate Specificity | 2 | 2008 | 1791 | 0.110 |
Why?
|
Alleles | 1 | 2004 | 6864 | 0.100 |
Why?
|
Uterine Neoplasms | 1 | 2021 | 1420 | 0.100 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 346 | 0.100 |
Why?
|
Gene Silencing | 3 | 2008 | 1509 | 0.100 |
Why?
|
Mice, Knockout | 2 | 2024 | 14417 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1768 | 0.100 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2012 | 38 | 0.100 |
Why?
|
Loss of Heterozygosity | 1 | 2014 | 662 | 0.100 |
Why?
|
Cell Physiological Phenomena | 1 | 2013 | 150 | 0.100 |
Why?
|
Chromosome Breakage | 1 | 2012 | 159 | 0.100 |
Why?
|
Sequence Alignment | 1 | 2016 | 2180 | 0.090 |
Why?
|
Gene Library | 1 | 2014 | 1059 | 0.090 |
Why?
|
Radiation, Ionizing | 1 | 2012 | 251 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5672 | 0.090 |
Why?
|
Recombination, Genetic | 3 | 2012 | 1519 | 0.090 |
Why?
|
Neoplasms | 5 | 2024 | 22173 | 0.090 |
Why?
|
Immunoprecipitation | 2 | 2010 | 878 | 0.090 |
Why?
|
Macaca mulatta | 1 | 2017 | 2329 | 0.090 |
Why?
|
DNA-Activated Protein Kinase | 2 | 2012 | 112 | 0.090 |
Why?
|
Enzyme Inhibitors | 4 | 2014 | 3713 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1092 | 0.090 |
Why?
|
Pyrazoles | 1 | 2020 | 2009 | 0.090 |
Why?
|
E2F2 Transcription Factor | 1 | 2009 | 35 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 2 | 2014 | 2467 | 0.080 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2009 | 85 | 0.080 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 13446 | 0.080 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2023 | 882 | 0.080 |
Why?
|
NF-kappa B | 1 | 2018 | 2490 | 0.080 |
Why?
|
Genes, cdc | 1 | 2009 | 114 | 0.080 |
Why?
|
Radiotherapy | 1 | 2016 | 1498 | 0.080 |
Why?
|
Hematopoietic System | 1 | 2009 | 110 | 0.080 |
Why?
|
Cell Proliferation | 6 | 2020 | 10451 | 0.080 |
Why?
|
Transcription Factors | 3 | 2020 | 12130 | 0.080 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2009 | 181 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 738 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1054 | 0.080 |
Why?
|
Aneuploidy | 1 | 2012 | 552 | 0.080 |
Why?
|
Bleomycin | 1 | 2009 | 494 | 0.070 |
Why?
|
Endopeptidases | 1 | 2012 | 774 | 0.070 |
Why?
|
Fibroblasts | 4 | 2019 | 4142 | 0.070 |
Why?
|
Gamma Rays | 1 | 2009 | 318 | 0.070 |
Why?
|
Baculoviridae | 1 | 2008 | 115 | 0.070 |
Why?
|
Computational Biology | 1 | 2020 | 3517 | 0.070 |
Why?
|
Antigens, Neoplasm | 2 | 2016 | 1993 | 0.070 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 57 | 0.070 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2007 | 91 | 0.070 |
Why?
|
Catalytic Domain | 1 | 2010 | 705 | 0.070 |
Why?
|
Subcellular Fractions | 1 | 2008 | 532 | 0.070 |
Why?
|
Protein Engineering | 2 | 2023 | 549 | 0.070 |
Why?
|
Chromosomes, Human | 1 | 2009 | 441 | 0.070 |
Why?
|
Models, Biological | 3 | 2012 | 9469 | 0.070 |
Why?
|
Antigens, Surface | 1 | 2011 | 1606 | 0.070 |
Why?
|
Protein Structure, Tertiary | 5 | 2014 | 3792 | 0.070 |
Why?
|
NM23 Nucleoside Diphosphate Kinases | 1 | 2006 | 21 | 0.070 |
Why?
|
Up-Regulation | 2 | 2021 | 4125 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 5314 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2017 | 2639 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2020 | 404 | 0.070 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2009 | 790 | 0.060 |
Why?
|
Genes, myc | 2 | 2020 | 390 | 0.060 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2021 | 424 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6815 | 0.060 |
Why?
|
Helminths | 1 | 2005 | 39 | 0.060 |
Why?
|
Doxorubicin | 1 | 2011 | 2224 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2898 | 0.060 |
Why?
|
Herpes Genitalis | 1 | 2005 | 150 | 0.060 |
Why?
|
Lung Neoplasms | 3 | 2016 | 13381 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12690 | 0.060 |
Why?
|
Herpesvirus 2, Human | 1 | 2005 | 191 | 0.060 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2418 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10090 | 0.060 |
Why?
|
Interferons | 3 | 2020 | 706 | 0.060 |
Why?
|
Mutation, Missense | 3 | 2009 | 2571 | 0.060 |
Why?
|
Models, Genetic | 1 | 2014 | 3442 | 0.060 |
Why?
|
Prostatic Neoplasms | 2 | 2020 | 11122 | 0.060 |
Why?
|
Recombinant Proteins | 3 | 2008 | 6534 | 0.060 |
Why?
|
Interleukin-7 | 1 | 2004 | 143 | 0.060 |
Why?
|
Adnexal Diseases | 1 | 2024 | 104 | 0.050 |
Why?
|
Radiation-Sensitizing Agents | 2 | 2018 | 350 | 0.050 |
Why?
|
RNA Editing | 1 | 2005 | 151 | 0.050 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 783 | 0.050 |
Why?
|
Cytidine Deaminase | 1 | 2005 | 243 | 0.050 |
Why?
|
Immunoglobulin Variable Region | 1 | 2004 | 419 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 666 | 0.050 |
Why?
|
Genetic Pleiotropy | 1 | 2024 | 181 | 0.050 |
Why?
|
Adenosine Deaminase | 1 | 2005 | 251 | 0.050 |
Why?
|
Morpholines | 2 | 2018 | 581 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14665 | 0.050 |
Why?
|
Kinetics | 1 | 2010 | 6374 | 0.050 |
Why?
|
Uridine | 1 | 2022 | 141 | 0.050 |
Why?
|
Telomerase | 2 | 2019 | 745 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1085 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9280 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4514 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2016 | 6131 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15266 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 101 | 0.050 |
Why?
|
Genome | 2 | 2019 | 1740 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2645 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 2005 | 1125 | 0.040 |
Why?
|
Rats | 3 | 2019 | 23741 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 1739 | 0.040 |
Why?
|
Cell Survival | 1 | 2010 | 5791 | 0.040 |
Why?
|
Aged | 7 | 2024 | 169310 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 1745 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2014 | 21019 | 0.040 |
Why?
|
Mammals | 1 | 2005 | 1132 | 0.040 |
Why?
|
Guanine | 1 | 2020 | 279 | 0.040 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2019 | 283 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 1704 | 0.040 |
Why?
|
Virus Diseases | 1 | 2005 | 718 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2020 | 1742 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2021 | 11120 | 0.040 |
Why?
|
Camptothecin | 2 | 2014 | 591 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 304 | 0.040 |
Why?
|
Middle Aged | 7 | 2024 | 220921 | 0.040 |
Why?
|
Pyrophosphatases | 1 | 2018 | 142 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2019 | 412 | 0.040 |
Why?
|
Proteomics | 2 | 2023 | 3848 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1055 | 0.040 |
Why?
|
Primates | 1 | 2019 | 523 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2018 | 18966 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4111 | 0.030 |
Why?
|
Pore Forming Cytotoxic Proteins | 2 | 2007 | 133 | 0.030 |
Why?
|
Male | 7 | 2024 | 360846 | 0.030 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2005 | 1841 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1003 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2822 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2116 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 959 | 0.030 |
Why?
|
Escherichia coli | 1 | 2008 | 4217 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1089 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22176 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2018 | 1693 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2005 | 2688 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 522 | 0.030 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 110 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 5035 | 0.030 |
Why?
|
DNA Helicases | 1 | 2019 | 851 | 0.030 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2014 | 70 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2014 | 184 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12723 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16592 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2231 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58984 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2007 | 3801 | 0.030 |
Why?
|
Protein Kinase C-alpha | 1 | 2014 | 113 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 962 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2020 | 5790 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 2226 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2018 | 1990 | 0.030 |
Why?
|
Hydroxyurea | 1 | 2014 | 284 | 0.030 |
Why?
|
Gene Regulatory Networks | 2 | 2014 | 1745 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7581 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 2014 | 355 | 0.030 |
Why?
|
Chromones | 1 | 2012 | 148 | 0.030 |
Why?
|
Glucose | 1 | 2024 | 4347 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2024 | 3313 | 0.020 |
Why?
|
Genetic Markers | 1 | 2018 | 2601 | 0.020 |
Why?
|
Mice, Nude | 1 | 2018 | 3614 | 0.020 |
Why?
|
Heterochromatin | 1 | 2014 | 293 | 0.020 |
Why?
|
Preoperative Period | 1 | 2014 | 551 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2012 | 237 | 0.020 |
Why?
|
Exosomes | 1 | 2016 | 424 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2004 | 9542 | 0.020 |
Why?
|
Piperidines | 1 | 2020 | 1656 | 0.020 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2011 | 56 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2020 | 2425 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2014 | 837 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 384 | 0.020 |
Why?
|
Carboplatin | 1 | 2014 | 794 | 0.020 |
Why?
|
Retinal Pigment Epithelium | 1 | 2014 | 303 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 687 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2013 | 504 | 0.020 |
Why?
|
Macrophages | 2 | 2020 | 5767 | 0.020 |
Why?
|
Radiometry | 1 | 2016 | 813 | 0.020 |
Why?
|
Chromosome Segregation | 1 | 2012 | 235 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1076 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1646 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2019 | 6228 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2024 | 3964 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6345 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2021 | 1853 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2018 | 1609 | 0.020 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2009 | 28 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4915 | 0.020 |
Why?
|
Adult | 5 | 2024 | 221210 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 368 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 17904 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3113 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2009 | 363 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2049 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39106 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2014 | 858 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2451 | 0.020 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2012 | 455 | 0.020 |
Why?
|
Staurosporine | 1 | 2009 | 242 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3617 | 0.020 |
Why?
|
Models, Chemical | 1 | 2009 | 611 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 678 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1371 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2811 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1171 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4425 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3878 | 0.020 |
Why?
|
Tandem Repeat Sequences | 1 | 2007 | 180 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4576 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5774 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6241 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41495 | 0.020 |
Why?
|
Caspases | 1 | 2009 | 879 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2018 | 3677 | 0.020 |
Why?
|
Administration, Intravaginal | 1 | 2005 | 150 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 2007 | 3701 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3605 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2007 | 392 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 891 | 0.020 |
Why?
|
Megakaryocytes | 1 | 2009 | 567 | 0.020 |
Why?
|
Receptors, HIV | 1 | 2005 | 159 | 0.010 |
Why?
|
Endosomes | 1 | 2007 | 522 | 0.010 |
Why?
|
Genes, Viral | 1 | 2005 | 649 | 0.010 |
Why?
|
Genes, Essential | 1 | 2005 | 185 | 0.010 |
Why?
|
Prognosis | 2 | 2016 | 29629 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15936 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 7968 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2112 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3597 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5870 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1756 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13510 | 0.010 |
Why?
|
COS Cells | 1 | 2005 | 1130 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 6032 | 0.010 |
Why?
|
Child | 2 | 2023 | 80158 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2828 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2006 | 754 | 0.010 |
Why?
|
Arginine | 1 | 2006 | 934 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2827 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2005 | 570 | 0.010 |
Why?
|
Liposomes | 1 | 2005 | 783 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 2005 | 561 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2065 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5205 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 64685 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3606 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2787 | 0.010 |
Why?
|
Vagina | 1 | 2005 | 838 | 0.010 |
Why?
|
Erythrocytes | 1 | 2009 | 2413 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4542 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 14033 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1784 | 0.010 |
Why?
|
Viral Proteins | 1 | 2005 | 1804 | 0.010 |
Why?
|
Virus Replication | 1 | 2005 | 2435 | 0.010 |
Why?
|
Lung | 1 | 2016 | 10002 | 0.010 |
Why?
|
Antibodies | 1 | 2005 | 2418 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 6214 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 3733 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11076 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59260 | 0.010 |
Why?
|
Genotype | 1 | 2007 | 12990 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88326 | 0.010 |
Why?
|
HIV-1 | 1 | 2005 | 6863 | 0.000 |
Why?
|
Inflammation | 1 | 2005 | 10774 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 39969 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 74213 | 0.000 |
Why?
|